Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 29:27:100382.
doi: 10.1016/j.metop.2025.100382. eCollection 2025 Sep.

Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis

Salya F Alfadli  1 , Yazeed S Alotaibi  2 , Maha J Aqdi  3 , Latifah A Almozan  4 , Zahra B Alzubaidi  5 , Hammad A Altemani  6 , Shaden D Almutairi  7 , Hussain A Alabdullah  8 , Alaa Ahmed Almehmadi  9 , Abdulrahman L Alanzi  10 , Ahmed Y Azzam  11
Affiliations

Effectiveness of continuous glucose monitoring systems on glycemic control in adults with type 1 diabetes: A systematic review and meta-analysis

Salya F Alfadli et al. Metabol Open. .

Erratum in

Abstract

Introduction: Continuous glucose monitoring (CGM) technologies have been advancing rapidly, but evidence on their comparative effectiveness stills limited to date yet. We conducted a systematic review and meta-analysis to evaluate and investigate the impact of CGM systems on glycemic control in adults with type 1 diabetes.

Methods: We searched electronic literature databases from inception through April 30, 2025, for comparative studies investigating CGM systems with standard monitoring or different CGM technologies in adults with type 1 diabetes. Primary outcomes included HbA1c reduction, time in range (TIR), and hypoglycemia reduction. We performed random-effects meta-analyses, network meta-analysis, and subgroup analyses by baseline HbA1c and intervention duration. Evidence quality was assessed using GRADE methodology.

Results: Twenty-seven studies with total of 2975 participants were included. CGM significantly reduced HbA1c compared to standard monitoring (mean difference: 0.38 %, 95 % CI: 0.49 to -0.27 %). TIR increased by 7.9 % (95 % CI: 5.8-10.0 %), representing 114 additional minutes daily in best range. Real-time CGM showed advantages over intermittently scanned CGM for TIR (+5.63 %, P-value<0.001) and hypoglycemia reduction (-1.28 %, P-value<0.001). Automated closed-loop systems achieved the highest ranking in network meta-analysis (SUCRA = 0.92). Benefits were greater among patients with higher baseline HbA1c (>8.5 %: 0.68 % reduction in HbA1c vs. <7.5 %: 0.24 % reduction in HbA1c, P-value = 0.009).

Conclusions: CGM technologies significantly improve glycemic control in adults with type 1 diabetes, with greater benefits for those with higher baseline HbA1c. Advanced systems demonstrate progressively greater improvements, with automated closed-loop systems showing the strongest evidence of effectiveness. These findings support broader implementation of CGM technologies, with selection tailored to individual patient needs.

Keywords: Continuous glucose monitoring; Diabetes; Glycemic control; HBA1C; Hyperglycemia.

PubMed Disclaimer

Conflict of interest statement

not applicable.

Figures

Fig. 1
Fig. 1
Prisma flowchart diagram.
Fig. 2
Fig. 2
Forest plot for multiple main comparisons.
Fig. 3
Fig. 3
Funnel plot of asymmetry and trim-and-fill c.orrection.
See this image and copyright information in PMC

References

    1. DiMeglio L.A., Evans-Molina C., Oram R.A.J.T.L. Type 1 diabetes. 2018;391(10138):2449–2462. - PMC - PubMed
    1. Azzam A.Y., et al. Epidemiological patterns of diabetes mellitus in the United States of America: an observational multicenter analysis from 1990 to 2024. ASIDE Internal Medicine. 2025;1(2):1–7. - PMC - PubMed
    1. Nassar M., et al. Investigating racial disparities in insulin pump use among people with type 1 diabetes across the United States: a retrospective multicenter study. 2025;1(1):20–25.
    1. Eichenlaub M., et al. 2025. Performance of three continuous glucose monitoring systems in adults with type 1 diabetes. - PMC - PubMed
    1. van Baal L., et al. 2025. Accuracy and reliability of intermittent scanning and real-time continuous glucose monitoring systems in diabetes emergencies. - PMC - PubMed

LinkOut - more resources